L084-0849 Screening compound: N-[2-(diethylamino)ethyl]-4-(3-{2-[1-(2-fluorophenyl)-N-methylformamido]ethyl}-1,2,4-oxadiazol-5-yl)benzamide

L084-0849 Screening compound: N-[2-(diethylamino)ethyl]-4-(3-{2-[1-(2-fluorophenyl)-N-methylformamido]ethyl}-1,2,4-oxadiazol-5-yl)benzamide
L084-0849 Screening compound: N-[2-(diethylamino)ethyl]-4-(3-{2-[1-(2-fluorophenyl)-N-methylformamido]ethyl}-1,2,4-oxadiazol-5-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L084-0849
N-[2-(diethylamino)ethyl]-4-(3-{2-[1-(2-fluorophenyl)-N-methylformamido]ethyl}-1,2,4-oxadiazol-5-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L084-0849

Molecular Formula

C25H30FN5O3 (C25 H30 FN5 O3)

Compound Name

N-[2-(diethylamino)ethyl]-4-(3-{2-[1-(2-fluorophenyl)-N-methylformamido]ethyl}-1,2,4-oxadiazol-5-yl)benzamide

IUPAC name

N-[2-(diethylamino)ethyl]-4-(3-{2-[1-(2-fluorophenyl)-N-methylformamido]ethyl}-124-oxadiazol-5-yl)benzamide

SMILES

CCN(CC)CCNC(c(cc1)ccc1-c1nc(CCN(C)C(c(cccc2)c2F)=O)no1)=O

InChI

InChI=1S/C25H30FN5O3/c1-4-31(5-2)17-15-27-23(32)18-10-12-19(13-11-18)24-28-22(29-34-24)14-16-30(3)25(33)20-8-6-7-9-21(20)26/h6-13H,4-5,14-17H2,1-3H3,(H,27,32)

InChI Key

AIAQVTGCJKLVAO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27229725

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

467.54

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.817

Distribution Coefficient, logD

1.703

Water Solubility, LogSw

-3.45

Polar Surface Area

76.973

Acid Dissociation Constant (pKa)

12.57

Base Dissociation Constant (pKb)

8.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.00

L084-0849 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

Antiviral Library (67538 compounds)

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with L084-0849 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L084-0849?
Check Price and Availability of L084-0849, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L084-0849 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L084-0849
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L084-0849
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L084-0849 available by request